标题
Wise Management of Ovarian Cancer: On the Cutting Edge
作者
关键词
-
出版物
Journal of Personalized Medicine
Volume 10, Issue 2, Pages 41
出版商
MDPI AG
发表日期
2020-05-21
DOI
10.3390/jpm10020041
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer
- (2020) Guotai Xu et al. NATURE GENETICS
- ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response
- (2020) Sankari Nagarajan et al. NATURE GENETICS
- Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
- (2020) Stergios Boussios et al. Drugs in research & development
- Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?
- (2020) Stergios Boussios et al. Annals of Translational Medicine
- Systemic anti-cancer treatment in malignant ovarian germ cell tumours (MOGCTs): current management and promising approaches
- (2020) Mario Uccello et al. Annals of Translational Medicine
- Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines
- (2019) Min-Kyung So et al. Breast Cancer
- Metformin in 2019
- (2019) James Flory et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
- (2019) Kathleen N Moore et al. LANCET ONCOLOGY
- Understanding malignant transformation of endometriosis: imaging features with pathologic correlation
- (2019) Kristin A. Robinson et al. Abdominal Radiology
- Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial
- (2019) Josep M. del Campo et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin improves the sensitivity of ovarian cancer cells to chemotherapeutic agents
- (2019) Chen Yang et al. Oncology Letters
- PARP Inhibitors in Ovarian Cancer: The Route to “Ithaca”
- (2019) Boussios et al. Diagnostics
- Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review
- (2019) Stergios Boussios et al. Diagnostics
- p53 Promotes chemoresponsiveness by regulating hexokinase II gene transcription and metabolic reprogramming in epithelial ovarian cancer
- (2019) Chae Young Han et al. MOLECULAR CARCINOGENESIS
- Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach
- (2019) Stergios Boussios et al. INVESTIGATIONAL NEW DRUGS
- New strategies in ovarian cancer treatment
- (2019) Jung‐Min Lee et al. CANCER
- Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
- (2019) Xin Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Inherited Cancer in the Age of Next-Generation Sequencing
- (2018) Kristin S. Price et al. Biological Research for Nursing
- The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case-control study
- (2018) E Urpilainen et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- An open-label, phase II basket study of olaparib and durvalumab (MEDIOLA): Results in germline BRCA -mutated ( gBRCA m) platinum-sensitive relapsed (PSR) ovarian cancer (OC)
- (2018) Y. Drew et al. GYNECOLOGIC ONCOLOGY
- PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation
- (2018) George E. Ronson et al. Nature Communications
- Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
- (2018) Elina Urpilainen et al. BMC CANCER
- The genetic landscape of 87 ovarian germ cell tumors
- (2018) Els Van Nieuwenhuysen et al. GYNECOLOGIC ONCOLOGY
- Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing
- (2018) Jacqueline Mersch et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- TOPACIO/Keynote-162 (NCT02657889): A phase 1/2 study of niraparib + pembrolizumab in patients (pts) with advanced triple-negative breast cancer or recurrent ovarian cancer (ROC)—Results from ROC cohort.
- (2018) Panagiotis A. Konstantinopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetics in ovarian cancer: premise, properties, and perspectives
- (2018) Qilian Yang et al. Molecular Cancer
- CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30+and CD30−Embryonal Carcinoma via Antigen-Dependent and Fas/FasL Interactions
- (2018) Lee K. Hong et al. Cancer Immunology Research
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian carcinosarcoma: Current developments and future perspectives
- (2018) Stergios Boussios et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer
- (2017) Christine Garcia et al. GYNECOLOGIC ONCOLOGY
- Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)
- (2017) Melissa Matz et al. GYNECOLOGIC ONCOLOGY
- Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2
- (2017) Amit M. Oza et al. GYNECOLOGIC ONCOLOGY
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Robert L Coleman et al. LANCET
- Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
- (2017) Elizabeth M Swisher et al. LANCET ONCOLOGY
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer
- (2017) Shan-Bing Wang et al. MEDICINE
- Synthetic Lethality Interaction Between Aurora Kinases and CHEK1 Inhibitors in Ovarian Cancer
- (2017) Ana Alcaraz-Sanabria et al. MOLECULAR CANCER THERAPEUTICS
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
- (2017) Catherine M Phelan et al. NATURE GENETICS
- Cancer-Associated Mutations in Endometriosis without Cancer
- (2017) Michael S. Anglesio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients
- (2017) Ettore Capoluongo et al. SEMINARS IN ONCOLOGY
- miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples
- (2017) Ovidiu-Leonard Braicu et al. OncoTargets and Therapy
- Metformin in combination with cisplatin inhibits cell viability and induces apoptosis of human ovarian cancer cells by inactivating ERK 1/2
- (2017) Jian‑Hong Dang et al. Oncology Letters
- Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy
- (2017) Mengjiao Li et al. Journal of Ovarian Research
- Aurora A kinase regulates non-homologous end-joining and poly(ADP-ribose) polymerase function in ovarian carcinoma cells
- (2017) Thuy-Vy Do et al. Oncotarget
- Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer
- (2017) Shinya Oki et al. Oncotarget
- Diabetic concentrations of metformin inhibit platelet-mediated ovarian cancer cell progression
- (2017) Rafaela Erices et al. Oncotarget
- Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies
- (2016) STERGIOS BOUSSIOS et al. ANTICANCER RESEARCH
- Cyclin-Dependent Kinase 4/6 Inhibition for the Treatment of Unresectable Mature Teratoma: Long-Term Follow-Up of a Phase II Study
- (2016) Vivek Narayan et al. Clinical Genitourinary Cancer
- Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015
- (2016) Mary B. Daly et al. Journal of the National Comprehensive Cancer Network
- (Partial) Loss of BAF250a (ARID1A) in rectovaginal deep-infiltrating endometriosis, endometriomas and involved pelvic sentinel lymph nodes
- (2016) G.M. Borrelli et al. MOLECULAR HUMAN REPRODUCTION
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
- (2016) Y. Pommier et al. Science Translational Medicine
- Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience
- (2016) Ming-Mo Hou et al. Oncotarget
- Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models
- (2015) Ernst Lengyel et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Evaluation of Effects of Metformin in Primary Ovarian Cancer Cells
- (2015) Seema Patel et al. Asian Pacific Journal of Cancer Prevention
- Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus
- (2015) Chin-Hsiao Tseng DIABETES-METABOLISM RESEARCH AND REVIEWS
- Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation
- (2015) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers
- (2015) Masafumi Kato et al. Journal of Gynecologic Oncology
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes
- (2014) Laurent Castéra et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Lack of association between deficient mismatch repair expression and outcome in endometrial carcinomas of the endometrioid type
- (2014) Irune Ruiz et al. GYNECOLOGIC ONCOLOGY
- Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
- (2014) Jonathan Ledermann et al. LANCET ONCOLOGY
- A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers
- (2014) Julie Bauman et al. Translational Oncology
- Chromatin Remodeling at DNA Double-Strand Breaks
- (2013) Brendan D. Price et al. CELL
- MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome
- (2013) Gregg S. Nelson et al. GYNECOLOGIC ONCOLOGY
- The significance of comprehensive staging surgery in malignant ovarian germ cell tumors
- (2013) Qian Liu et al. GYNECOLOGIC ONCOLOGY
- Cellular, Histologic, and Molecular Changes Associated With Endometriosis and Ovarian Cancer
- (2013) João Siufi Neto et al. Journal of Minimally Invasive Gynecology
- Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion
- (2013) T-V Do et al. ONCOGENE
- Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells
- (2013) Yanfang Li et al. Frontiers in Oncology
- Role of EZH2 in Epithelial Ovarian Cancer: From Biological Insights to Therapeutic Target
- (2013) Hua Li et al. Frontiers in Oncology
- Metformin intake is associated with better survival in ovarian cancer
- (2012) Sanjeev Kumar et al. CANCER
- Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3
- (2012) Siqing Fu et al. CANCER BIOLOGY & THERAPY
- Aurora Kinase-A Inactivates DNA Damage-Induced Apoptosis and Spindle Assembly Checkpoint Response Functions of p73
- (2012) Hiroshi Katayama et al. CANCER CELL
- Metformin targets ovarian cancer stem cells in vitro and in vivo
- (2012) Jessica J. Shank et al. GYNECOLOGIC ONCOLOGY
- Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?
- (2012) Eleftherios P Samartzis et al. MODERN PATHOLOGY
- Germline RAD51C mutations confer susceptibility to ovarian cancer
- (2012) Chey Loveday et al. NATURE GENETICS
- Metformin inhibits the development and metastasis of ovarian cancer
- (2012) BUCHU WU et al. ONCOLOGY REPORTS
- 5-Aza-2′-deoxycytidine Leads to Reduced Embryo Implantation and Reduced Expression of DNA Methyltransferases and Essential Endometrial Genes
- (2012) Yu-Bin Ding et al. PLoS One
- Induction of apoptosis by metformin in epithelial ovarian cancer: Involvement of the Bcl-2 family proteins
- (2011) Amber Yasmeen et al. GYNECOLOGIC ONCOLOGY
- Use of metformin and the risk of ovarian cancer: A case–control analysis
- (2011) Michael Bodmer et al. GYNECOLOGIC ONCOLOGY
- Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity
- (2011) Iris L. Romero et al. OBSTETRICS AND GYNECOLOGY
- Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia
- (2011) E J Gallagher et al. ONCOGENE
- Targeting the Phosphatidylinositol 3-Kinase Signaling Pathway in Breast Cancer
- (2011) L. F. Hernandez-Aya et al. ONCOLOGIST
- ENMD-2076 Is an Orally Active Kinase Inhibitor with Antiangiogenic and Antiproliferative Mechanisms of Action
- (2010) G. C. Fletcher et al. MOLECULAR CANCER THERAPEUTICS
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lynch Syndrome in Women Less Than 50 Years of Age With Endometrial Cancer
- (2010) Kellie S. Matthews et al. OBSTETRICS AND GYNECOLOGY
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system
- (2009) José Alejandro Pérez Fidalgo et al. Clinical & Translational Oncology
- A Phase I Dose-Escalation Study of Danusertib (PHA-739358) Administered as a 24-Hour Infusion with and without Granulocyte Colony-Stimulating Factor in a 14-Day Cycle in Patients with Advanced Solid Tumors
- (2009) R. B. Cohen et al. CLINICAL CANCER RESEARCH
- Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer
- (2009) M P Hitchins et al. JOURNAL OF MEDICAL GENETICS
- Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells
- (2009) Christopher D Scharer et al. Journal of Translational Medicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search